Markets
US equities, global indices, bonds, futures and live market data
Markets News
Dow Jones Slides as Netflix Plunges on Earnings Miss; SpaceX Also Under Pressure
The Dow Jones Industrial Average dropped on Friday as Netflix stock plunged on earnings results while SpaceX-linked shares also came under pressure, reflecting a mixed end to the week for the US equity market.
Jul 18, 2026
🇺🇸 United StatesAehr Test Systems (AEHR) Surges as End Markets Pivot From EVs to AI Processors, Order Book Grows
Aehr Test Systems surged this week after confirming its end markets have evolved from EV power semiconductors to AI processor testing, with burgeoning order growth signaling that AI chip manufacturers are investing in wafer-level burn-in equipment.
Jul 18, 2026
🇺🇸 United StatesOppenheimer Issues Warning on IBM After Sharp Share Price Crash: 'The Most Dangerous Moment'
Oppenheimer issued a cautionary note on IBM following a sharp decline in the company's share price, warning that the 'most dangerous moment for a stock is when the last true bulls turn' — signaling concern about IBM's AI monetization narrative.
Jul 18, 2026
🇺🇸 United States1.2 Million Korean Retail 'Ant' Investors Hit With Margin Calls as Korean Market Crash Ripples Across Asia
More than 1.2 million South Korean retail investors — over 3% of the adult population — received margin calls as the Korean market crash sent ripple effects across Asian equity markets during a brutal week for leveraged stock traders.
Jul 18, 2026
🇺🇸 United StatesColes Group (COL.AX) Ends Talks With TPG Capital on Greencross Pet Wellness Acquisition
Australia's Coles Group has ceased discussions with TPG Capital's private equity group regarding a potential acquisition of Greencross Pet Wellness, ending an acquisition process that had attracted market speculation.
Jul 18, 2026
🇺🇸 United StatesFreedom Metals Acquisition Corp SPAC Terminates Prior Deal and Signs New Business Combination With PIPE Financing
Freedom Metals Acquisition Corp filed four 8-K reports in a single day covering deal termination, a new material agreement, PIPE financing, and articles amendment — the regulatory disclosure pattern of an active SPAC deal pivot.
Jul 18, 2026
🇺🇸 United StatesLucid Motors (LCID) Soars 29% as EV Maker Calls Bankruptcy Rumors 'Completely False'
Lucid Motors shares surged ~29% after the company denied bankruptcy rumors as 'completely false' — following a mid-week crash that erased over half its value on speculation reports.
Jul 18, 2026
🇺🇸 United StatesTribeca Strategic Acquisition Corp Files Dual 8-Ks Covering Management Changes and Material Events
Tribeca Strategic Acquisition Corp filed two 8-K reports on July 17 covering director/officer changes (Item 5.02) and other events (Item 8.01) — SEC disclosures typical of a SPAC in active deal or extension proceedings.
Jul 18, 2026
Live Markets
Economic Calendar
Advertisement
More Markets Stories
RxSight (RXST) Surges 6.1% on Above-Average Volume as Medical Device Stock Attracts Buyers
RxSight Inc. (RXST) jumped 6.1% in above-average trading volume, with investors rotating into the medical device maker as its light-adjustable lens technology gains clinical adoption momentum.
Jul 18, 2026
🇺🇸 United StatesAsian Tech Stocks Plunge as US Semiconductor Selloff in NVDA and SMH ETF Spreads Globally
Asian technology stocks fell sharply as US semiconductor selling — with NVIDIA (NVDA) and the SMH semiconductor ETF both under pressure — spread contagion to Asian equity markets amid AI overvaluation concerns.
Jul 18, 2026
🇺🇸 United StatesSeven & i Holdings Eyes European Expansion With Potential Zabka Group Acquisition
Seven & i Holdings, parent of 7-Eleven, is reportedly evaluating a potential acquisition of Zabka Group, the dominant Polish convenience store chain, as it pursues strategic expansion beyond its core US and Asian markets.
Jul 18, 2026
🇺🇸 United StatesJasper Therapeutics (JSPR) Completes Kira Acquisition, Eyes Multiple Clinical Milestones Through 2027
Jasper Therapeutics completed its acquisition of Kira, expanding its clinical-stage biotechnology pipeline as the company eyes multiple clinical milestones through 2027 on its lead stem cell and immune system programs.
Jul 18, 2026